FAQ
Frequently asked Questions
Vantage is our data intelligence solution built for medtech companies. It consolidates real-world procedure volumes, growth metrics, and regional insights into a single, intuitive dashboard—enabling data-driven strategies and faster, more confident decisions.
Vantage is designed for medtech companies, market researchers, and decision-makers who need access to reliable, up-to-date procedure data to guide strategy, market entry, and product development.
We aggregate data from trusted healthcare institutions and public health databases, ensuring comprehensive coverage and factual information. Our data undergoes rigorous validation, cleaning, structuring, and translation (if needed) to ensure accuracy and consistency.
Transparency is a core principle of Vantage. Each country has a dedicated information box within the platform that provides detailed insights into data accuracy, sources, and methodology. We clearly indicate data limitations, coverage gaps, and any estimations used, ensuring that users fully understand the reliability of the insights they are working with. Our goal is to provide full transparency, allowing MedTech companies to make decisions with confidence and clarity.
Our data is regularly updated in sync with the latest available datasets, ensuring you always work with the latest market insights.
Our platform offers global coverage, focusing on the nine most important markets across North America, Europe, Asia, and Oceania, with detailed insights across nearly 200 regions. We track a wide range of surgical and medical procedures, allowing users to filter by procedure type, year, and region for precise analysis. The specific procedures available depend on the classification system used in each country, ensuring alignment with local healthcare standards.
Yes. Vantage allows users to filter data by region, procedure type, and time period, enabling precise comparisons within each country to assess market performance, identify trends, and evaluate opportunities. However, procedures cannot be directly compared between countries due to differences in national classification systems. Through our experience, we know that attempting to standardize across systems is highly complex, prone to inaccuracies, and ultimately unreliable. Instead, our platform ensures accurate, region-to-region comparisons within each country, allowing for accurate and meaningful insights.
Yes. Vantage provides historical and factual data from 2018 to 2023 in most cases, along with projections extending until 2028. Our platform offers multi-year trends and predictive modeling to help you anticipate shifts in procedure demand and market expansion opportunities.
Yes. Our platform provides access to raw data tables, which can be exported into your preferred analytics tools or spreadsheets for deeper analysis.
We provide personalized demos to walk you through the platform and showcase its capabilities. Contact us via info@hadronhealth.com to request a demo.
We offer a simple, flat-fee pricing model based on the number of users, giving you full access to all countries and regions without additional costs. Subscriptions are available as annual or multi-year plans, with discounts for longer commitments. This ensures affordability and flexibility, making it easy for teams of any size to access global procedure insights.
Your subscription grants full access to 9 key countries and nearly 200 regions, with regular data refreshes directly on the platform. It includes historical procedure data (2018-2023), forecasts through 2028, and new country additions as they become available. Users can filter, compare, and export insights in Excel, PowerPoint, or PDF, with full transparency on data accuracy and sources.
To explore how Hadron Health can support your medtech strategy, request a demo or contact our team for a quote via info@hadronhealth.com.